UK's MedPharm has received a Department of Trade and Industry (DTI)
grant for Research and Development to produce its new spray
treatment for eczema, expected to be available in the US by 2009.
Celsis International has signed a collaboration with BioVentures to
develop a microarray-based microbiological testing system to detect
contamination in pharmaceutical, biotechnology and other process
industries.
The US Supreme Court's decision as to how much a patent can
restrict research conducted by another company is a question that
is certain to affect the way innovative new drugs are researched
and developed.
India's new patent law, that will prevent domestic pharmaceutical
manufacturers from making low-cost generic copies of in-patent
drugs - has finally been passed by the lower house of the country's
parliament, writes Phil...
BioPartners, currently leading the line amongst companies trying to
bring copies of off-patent biologic drugs to the European market,
has licensed a needle-free delivery technology for its human growth
hormone (hGH) product.
Applera suffered a setback to its European sector after the
European Patent Office revoked its patent covering real-time PCR
thermal cycler technology.
With just a few weeks to go before the introduction of India's new
patent regime - which will increase protection to include product
as well as process patents - a group of government Ministers is
calling for a waiver that would...
India is gearing up for the introduction of new legislation on
intellectual property that will bring it into line with its World
Trade Organisation commitments.
In a dispute with Stanelco Fibre Optics, Bioprogress Technology has
been awarded outright ownership of a master patent giving it
exclusive rights to the process of making capsules from
non-gelatine materials by means of radio frequency...
Netherlands firm Pharming has acquired the patent portfolio of
former transgenic protein production specialist PPL Therapeutics,
at a stroke enhancing its proprietary position in this emerging
market.
A clear legal basis has been established for the first time which
will enable research institutions to use molecular biology
techniques for which provate companies have dominant patent
positions without signing away the rights to...
The Chinese pharmaceutical industry is still showing above average
growth, but the country's entry into the World Trade Organisation
means that tough times are ahead for manufacturers of active
pharmaceutical ingredients - which...
Switzerland's Novartis has been awarded a US patent for a novel
means of extending the shelf life of pharmaceuticals. The invention
describes the use of a plastic bottle made from a polymeric
material that is impregnated with...
High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
Screening.'
